Early ERT Use May Lessen Hearing Loss in Infantile-onset Pompe

Early ERT Use May Lessen Hearing Loss in Infantile-onset Pompe

305159

Early ERT Use May Lessen Hearing Loss in Infantile-onset Pompe

Starting treatment with enzyme-replacement therapy (ERT) in the first days of life appears to lessen the risk of hearing impairments in children with infantile-onset Pompe disease (IOPD), researchers report. “Our study may enhance awareness of early intervention before hearing-related morbidities can develop in patients with IOPD,” its researchers wrote. The study, “Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy,” was published in the Orphanet Journal of Rare Diseases. Pompe disease is caused by deficiency…

You must be logged in to read/download the full post.